About Prolaio
Transforming real-world cardiac data into faster discovery today and precision care for functional cures tomorrow.
- Industry
- Technology, Information and Internet
- Company size
- 51-200 employees
- Headquarters
- Chicago, IL
- Founded
- 2022
- Company type
- Privately Held
Prolaio, Inc. is a digital health technology company, focused on developing medical devices and platforms for cardiovascular research and care. Our platform supports remote collection of data that may help generate insights into cardiovascular conditions and diseases.
The company was created by cardiologists, cardiovascular practitioners, and data scientists specifically to address the world’s number one cause of death - cardiovascular disease.
We envision a future where care teams and hospitals are more effective, the healthcare system is more efficient, researchers have greater confidence in their trials, and new drugs accelerate to market - so more patients have access to better care, improved outcomes, and healthier lives.
This is precision cardiology, and we know it’s within reach. Join us on a mission to build today’s real-world insights for tomorrow’s cardiology.
Specialties
- Cardiology
- Digital Health
- Patient Engagement
- Data Science
- Health Data Applications
- Software
- Remote Monitoring
- Healthcare Technology
- and SaaS
Company locations
Chicago, IL, US
Locations listed on the company profile. These may include offices outside the United States, and not every location is hiring.
Business areas
- Health Care
- Analytics
- Medical
On LinkedIn
- Followers
- 6,360
- People linked to this company
- 77
People who list this company on LinkedIn, not a verified employee count. Figures reflect the saved company profile.
Funding raised
25,499,985 USD
Total reported by Crunchbase, in US dollars. This is funding raised, not company revenue or valuation.
Explore the company
Employer category
Other employer
Estimated from the company profile. This category has not been confirmed by the employer.